Clinical Trials Directory

Trials / Completed

CompletedNCT04001530

Half-normal Saline in Atrial Flutter Ablation

Verification of Half Normal Saline as a Superior Irrigant in the Catheter Radiofrequency Ablation of Typical Cavotricuspid Isthmus Dependent Atrial Flutter: A Multicenter Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
4 (actual)
Sponsor
Sunnybrook Health Sciences Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

To assess the acute and long-term efficacy of half-normal saline compared to normal saline for irrigation of open-irrigated catheters during catheter ablation for the treatment of cavotricuspid isthmus dependent atrial flutter.

Detailed description

It is unclear whether ionic strength affects energy delivery and ablation lesion size during radiofrequency ablation for atrial flutter. Given that saline contains ionic sodium and chloride in the solution, it has conductive properties that may disperse radiofrequency energy away from the tip-tissue interface, thereby reducing current density and lesion size compared to ablation with nonionic solutions. The efficacy of half-normal saline will be measured by the time taken to create bidirectional block across the cavotricuspid isthmus as well as the acute recurrence rate within 30 minutes of the initial occurrence of bidirectional block and the 1 year freedom from flutter recurrence.

Conditions

Interventions

TypeNameDescription
DRUGHalf Normal Saline 0.45% Infusion Solution BagRandomization to half normal saline
DRUGNormal Saline 0.9% Infusion Solution BagRandomization to normal saline

Timeline

Start date
2018-01-01
Primary completion
2021-01-31
Completion
2021-01-31
First posted
2019-06-28
Last updated
2021-07-06

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT04001530. Inclusion in this directory is not an endorsement.